Edition:
India

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

24.14CNY
16 Jan 2018
Change (% chg)

¥0.20 (+0.84%)
Prev Close
¥23.94
Open
¥23.85
Day's High
¥24.56
Day's Low
¥23.70
Volume
7,385,174
Avg. Vol
6,844,966
52-wk High
¥25.58
52-wk Low
¥18.28

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 0.29 December 17 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 6 6
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.45 1.45

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 1,278.66 1,278.66 1,278.66 1,458.47
Quarter Ending Jun-18 1 1,704.88 1,704.88 1,704.88 1,944.63
Year Ending Dec-18 8 6,731.75 7,141.67 6,301.00 7,281.71
Earnings (per share)
Quarter Ending Mar-18 1 0.29 0.29 0.29 0.34
Quarter Ending Jun-18 1 0.39 0.39 0.39 0.46
Year Ending Dec-18 8 1.19 1.47 1.12 1.55

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1,403.22 1,680.15 276.93 19.74
Quarter Ending Jun-17 1,489.78 1,547.84 58.06 3.90
Quarter Ending Mar-17 1,373.81 1,528.05 154.24 11.23
Quarter Ending Dec-16 1,615.26 1,346.56 268.70 16.64
Quarter Ending Sep-16 1,409.79 1,302.33 107.45 7.62

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1,278.66 1,278.66 1,278.66 1,278.66 1,458.47
Quarter Ending Jun-18 1,704.88 1,704.88 1,704.88 1,704.88 1,944.63
Year Ending Dec-18 6,731.75 6,747.28 6,747.28 6,747.28 7,281.71

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings